EL
25
4
SNA
68
-2
PEP
48
6
CMG
72
5
NWS
66
-3
EBAY
47
4
WFC
79
4
GOOG
50
-3
EOG
58
2
MAT
46
12
DOW
44
10
XRAY
28
2
HBI
59
4
EXC
53
-3
TDC
80
4
BA
54
5
F
58
11
CF
57
-2
DTE
56
2
URBN
56
14
EL
25
4
SNA
68
-2
PEP
48
6
CMG
72
5
NWS
66
-3
EBAY
47
4
WFC
79
4
GOOG
50
-3
EOG
58
2
MAT
46
12
DOW
44
10
XRAY
28
2
HBI
59
4
EXC
53
-3
TDC
80
4
BA
54
5
F
58
11
CF
57
-2
DTE
56
2
URBN
56
14
Financhill
Back

Bioxytran 10K Form

Sell
30

BIXT
Bioxytran

Last Price:
0.1000
Seasonality Move:
294.65%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BIXT News And Ratings

See the #1 stock for the next 7 days that we like better than BIXT

BIXT Financial Statistics

Sales & Book Value

Annual Sales: $191.08K
Cash Flow: $21.2K
Price / Cash Flow: 0
Annual Sales: $-0.01
Price / Book: 0

Profitability

EPS (TTM): -0.01180
Net Income (TTM): $-2.81M
Gross Margin: $87.1K
Return on Equity: 0%
Return on Assets: 0%

Bioxytran Earnings Forecast

Key Bioxytran Financial Ratios

  • The Gross Profit Margin over the past 10 years for BIXT is 45.58%.
  • The Selling, General & Administrative Expenses for BIXT have been equal to 208.13% of Gross Profit Margin.
  • The Interest Expense is -12.66% of Operating Income.
  • Per Share Earnings over the last 16 years have been positive in 8 years.

Bioxytran Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Health Care
Current Symbol: BIXT
Website: bioxytraninc.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BIXT Technical Analysis vs Fundamental Analysis

Sell
30
Bioxytran (BIXT) is a Sell

Is Bioxytran a Buy or a Sell?

  • Bioxytran stock is rated a Sell
    The current Bioxytran [BIXT] share price is $0.0960. The Score for BIXT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.